glp 1 pancreatic cancer GLP-1 and cancer-New Study, ., article text provided outlines a landmark clinical study recently shared at the American Society for Clinical Oncology (ASCO) annual conference., ### Key Research suggests popular diabetes drugs

Even more notably, about a quarter of these women described their appetite reduction as "significant." 100% of the women in the Supresa group reported decreased hunger sensations Weight Management : While modest, the Supresa group showed statistically significant weight loss compared to placebo, losing 2.12 pounds over the 8-week period without any dietary restrictions

Patient Scenarios: Real World Decision Making Sarah, 52, with type 2 diabetes and heart disease : Sarahs provider chose Ozempic over Trulicity specifically because cardiovascular outcome trials demonstrated significant reductions in major adverse cardiac events with semaglutide

This review describes in detail the beneficial effects of GLP-1 RA on the central pathological mechanisms of diabetes and related degenerative diseases

This has led to a focus on signaling pathways and neuroendocrine mechanisms to develop targeted obesity treatments

GLP-1 drugs are authorised for weight loss, and none are intended for cosmetic or aesthetic uses